 valu mca CA cea discrimin metastat breast cancer adenocarcinoma primari site mca CA cea CA serum patient metastat breast cancer patient metastat adenocarcinoma primari site percentil normal valu distribut cut-off point posit predict valu pv+ CI mca CI CA receiver-operating-characterist roc curv pv+ CA CI cut-off point except patient mca mca CA patient breast cancer posit mca CA neg cea CA improv pv+ CI mca CA use role discrimin patient metastat breast cancer adenocarcinoma primari site